Filtros de búsqueda

Lista de obras de Armin Ghobadi

A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma

artículo científico publicado en 2019

A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma

artículo científico publicado en 2019

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

artículo científico publicado en 2018

An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies.

artículo científico publicado en 2018

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

artículo científico publicado en 2017

Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma: Practical Implications for the Community Oncologist

scientific article published on 04 October 2019

Bortezomib is a rapid mobilizer of hematopoietic stem cells in mice via modulation of the VCAM-1/VLA-4 axis

artículo científico publicado en 2014

CAR-T therapy in Solid Organ Transplant Recipients with Treatment Refractory Post Transplant Lymphoproliferative Disorder

artículo científico publicado en 2020

Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant.

artículo científico publicado en 2016

Chimeric antigen receptor T cell therapy for non-Hodgkin lymphoma.

artículo científico publicado en 2018

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation

artículo científico publicado en 2018

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Tran

scientific article published on 15 May 2019

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation

scientific article published on 01 May 2020

DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma

artículo científico publicado en 2020

Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML.

artículo científico publicado en 2017

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission

artículo científico publicado en 2013

Fresh or Cryopreserved CD34+-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplantation.

artículo científico publicado en 2017

HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant

scientific article published on 23 January 2019

Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?

artículo científico publicado en 2020

Impact of comorbidity on initial treatment and overall survival in elderly head and neck cancer patients.

artículo científico publicado en 2014

Ixazomib, an oral proteasome inhibitor, induces rapid mobilization of hematopoietic progenitor cells in mice.

artículo científico publicado en 2018

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial

artículo científico publicado en 2018

Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma

scientific article published on 28 August 2019

Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment

scientific article published on 21 June 2018

Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study

scientific article published on 19 January 2019

Outcomes of Patients with Large B-cell Lymphoma Progressing after Axicabtagene Ciloleucel

artículo científico publicado en 2020

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.

artículo científico publicado en 2017

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

artículo científico publicado en 2017

Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation.

artículo científico publicado en 2016

Phase II Study of Propylene Glycol-Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

artículo científico publicado en 2016

Rectal GI stromal tumor mimicking a prostate mass

artículo científico publicado en 2007

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

scientific article published on 01 March 2020

Salvage second hematopoietic cell transplantation in myeloma

artículo científico publicado en 2013

Secondary acute lymphoblastic leukemia, a retrospective analysis from Washington University and meta-analysis of published data

artículo científico publicado en 2018

Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia

scientific article published on 21 November 2019

Shared cell of origin in a patient with Erdheim-Chester disease and acute myeloid leukemia

scientific article published on 28 March 2019

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

scientific article published on 13 May 2020

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

artículo científico publicado en 2016

The use of ruxolitinib for acute graft-versus-host disease developing after solid organ transplantation

artículo científico publicado en 2019

Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study

artículo científico publicado en 2019

Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma

artículo científico publicado en 2020

[(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda